EVALUATION OF INCREASING TREND OF PHARMACOECONOMICS AND OUTCOMES RESEARCH IN LEADING INSTITUTES OF INDIA

Author(s)

Ligade V, Udupa N
Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

Pharmacoeconomics, health outcomes research and patient-reported outcomes in particular focuses on understanding patient value in terms of impact of disease and its treatment on physical functioning and psychosocial wellbeing. Pharmacoeconomics and health outcomes research is developing field in India. To study and find out the trend of pharmaceconomics and outcome research contributed by Indian institutions. In order to meet the objective, required information was collected through scientific presentations database of International Society for pharmacoeconomics and outcomes research (ISPOR). The scientific presentations database was searched with key word “India”. The website includes presentations from all ISPOR international meetings since 1998. The abstracts published till 2017 were included in the study. From the ISPOR scientific database search it was found that research abstract paper in ISPOR meetings have been steadily increasing with around 573 papers being published by Indian authors. 198 research abstract papers were published with foreign authors, which is most encouraging trend. In India, some of the leading group of institutions that had published research abstract papers were - Manipal Academy of Higher Education (142), NIPER (47), Novartis Healthcare Pvt. Ltd. Hyderabad (28), JSS College of Pharmacy (31), PAREXEL International, Chandigarh (18), Tata Consultancy Services, (12), and Chalapathi Institute of Pharmaceutical Sciences, Guntur (10). Other leading institutes are also discussed in the study. Indian researchers at some leading institutes are carrying out research along with foreign researchers, which is encouraging trend. At present research in this upcoming field is limited to only few institutes. There are some challenges like lack of awareness about the concepts and methods, shortage of skilled technical workforce, insufficient funding for the said research. In future, to strengthen the research, we require training workshops, research funding from the government and organizing conferences, symposia to share best practices at the national and international level.

Conference/Value in Health Info

2018-09, ISPOR Asia Pacific 2018, Tokyo, Japan

Value in Health, Vol. 21, S2 (September 2018)

Code

PCP10

Topic

Health Policy & Regulatory

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×